HealthStream, Inc.

How big is HealthStream, Inc.?

As of Jun 18, HealthStream, Inc. has a market capitalization of 836.09 million, with net sales of 292.36 million and a net profit of 19.11 million over the last four quarters. Shareholder's funds are 359.36 million, and total assets amount to 522.75 million.

As of Jun 18, HealthStream, Inc. has a market capitalization of 836.09 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 292.36 million for the latest four quarters and a net profit of 19.11 million during the same period.<BR><BR>As of Dec 24, the balance sheet shows shareholder's funds of 359.36 million and total assets amounting to 522.75 million.

What does HealthStream, Inc. do?

HealthStream, Inc. provides workforce and provider solutions for healthcare organizations and operates in the Software Products industry. As of March 2025, it reported net sales of $73 million and a net profit of $4 million, with a market cap of $836.09 million.

Overview:<BR>HealthStream, Inc. provides workforce and provider solutions for healthcare organizations and operates within the Software Products industry, categorized as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 73 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 4 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 836.09 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 46.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.31 <BR>Return on Equity: 5.27% <BR>Price to Book: 2.30<BR><BR>Contact Details:<BR>Address: 500 11th Ave N Ste 1000, NASHVILLE TN: 37203-3384 <BR>Tel: 1 615 3013100 <BR>Fax: 1 615 3013200 <BR>Website: https://www.healthstream.com/

Should I buy, sell or hold HealthStream, Inc.?

Who are in the management team of HealthStream, Inc.?

As of March 2022, the management team of HealthStream, Inc. includes Chairman and CEO Mr. Robert Frist, Lead Independent Director Mr. Thompson Dent, and independent directors Mr. Frank Gordon, Dr. C. Martin Harris, Mr. Jeffrey McLaren, and Ms. Linda Rebrovick.

As of March 2022, the management team of HealthStream, Inc. includes Mr. Robert Frist, who serves as the Chairman of the Board and Chief Executive Officer. Additionally, the board features Mr. Thompson Dent as the Lead Independent Director, along with independent directors Mr. Frank Gordon, Dr. C. Martin Harris, Mr. Jeffrey McLaren, and Ms. Linda Rebrovick.

Is HealthStream, Inc. technically bullish or bearish?

As of August 21, 2025, HealthStream, Inc. has shifted to a mildly bearish trend with mixed technical signals, underperforming the S&P 500 over the past year and year-to-date, but showing stronger returns over the 3-year and 5-year periods.

As of 21 August 2025, the technical trend for HealthStream, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by daily moving averages indicating a bearish signal, while the weekly MACD and KST show mild bullishness. The Bollinger Bands present a bullish signal on the weekly but are mildly bearish on the monthly. Overall, the mixed signals suggest a lack of strong momentum in either direction. <BR><BR>In terms of performance, HealthStream has underperformed the S&P 500 over the year and year-to-date, with returns of -0.44% and -8.27% respectively, compared to 17.14% and 12.22% for the benchmark. However, it has shown stronger returns over the 3-year and 5-year periods, at 34.49% and 44.69%, respectively, compared to the S&P 500's 70.41% and 96.61%.

Is HealthStream, Inc. overvalued or undervalued?

As of October 31, 2025, HealthStream, Inc. is fairly valued with a P/E ratio of 46 and an EV to EBITDA of 12.29, showing a more reasonable valuation compared to peers like Enfusion and Cerence, despite underperforming the S&P 500 with a year-to-date return of -18.14%.

As of 31 October 2025, the valuation grade for HealthStream, Inc. has moved from expensive to fair. The company appears to be fairly valued based on its current metrics. Key ratios include a P/E ratio of 46, an EV to EBITDA of 12.29, and a PEG ratio of 6.67, which suggest that while the company is not undervalued, it is also not excessively priced compared to its peers.<BR><BR>In comparison to its peers, HealthStream, Inc. has a P/E ratio of 40.95, which is lower than the significantly high P/E ratios of Enfusion, Inc. at 260.46 and Cerence, Inc. at 409.37, indicating a more reasonable valuation within the software products industry. However, the company has underperformed against the S&P 500 over multiple periods, with a year-to-date return of -18.14% compared to the S&P 500's 16.30%, which may reflect broader market trends or company-specific challenges.